Teleflex (TFX) Cash from Financing Activities (2009 - 2026)
Teleflex (TFX) reported Cash from Financing Activities of -$45.0 million for Q1 2026, up 24.43% on a YoY basis from -$36.2 million in Q1 2025, and up 26.98% quarter-over-quarter from -$61.6 million in Q4 2025.
Teleflex (TFX) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Teleflex has reported Cash from Financing Activities for 18 years, with the latest figure at -$45.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 24.43% year-over-year to -$45.0 million; the trailing twelve-month figure through Mar 2026 stood at $626.1 million (up 252.7% YoY), and the FY2025 full-year result was $611.5 million, up 244.94% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$45.0 million, up from -$61.6 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $756.3 million in Q3 2025, with the low at -$237.5 million in Q4 2023.
- Historically, Cash from Financing Activities has averaged -$2.0 million across 5 years, with a median of -$59.5 million in 2025.
- The largest YoY upside for Cash from Financing Activities was 1904.6% in 2023 against a maximum downside of 1286.22% in 2023.
- Teleflex's Cash from Financing Activities stood at -$17.1 million in 2022, then slumped by 1286.22% to -$237.5 million in 2023, then surged by 49.85% to -$119.1 million in 2024, then soared by 48.28% to -$61.6 million in 2025, then advanced by 26.98% to -$45.0 million in 2026.
- The last three Cash from Financing Activities figures came in at -$45.0 million (Q1 2026), -$61.6 million (Q4 2025), and $756.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Teleflex | 5.67 Bn | 5.36 Bn | 307.43 Mn | -44.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.99 Mn |
| Mar 31, 2026 | -44.99 Mn |
| Dec 31, 2025 | -61.61 Mn |
| Dec 31, 2025 | -61.61 Mn |
| Sep 28, 2025 | 756.34 Mn |
| Sep 28, 2025 | 756.34 Mn |
| Jun 29, 2025 | -23.67 Mn |
| Jun 29, 2025 | -23.67 Mn |
| Mar 30, 2025 | -59.52 Mn |
| Mar 30, 2025 | -59.52 Mn |
| Dec 31, 2024 | -119.12 Mn |
| Dec 31, 2024 | -119.12 Mn |
| Sep 29, 2024 | -174.82 Mn |
| Sep 29, 2024 | -174.82 Mn |
| Jun 30, 2024 | -56.54 Mn |
| Jun 30, 2024 | -56.54 Mn |
| Mar 31, 2024 | -71.45 Mn |
| Mar 31, 2024 | -71.45 Mn |
| Dec 31, 2023 | -237.50 Mn |
| Dec 31, 2023 | -237.50 Mn |